Neuroimaging biomarkers as predictors of treatment outcome in Major Depressive Disorder

Journal of Affective Disorders

Volumn 233, Issue , 2018, Pages 21-35

  Fonseka, Trehani M ^a,b   MacQueen, Glenda M ^c,d,e   Kennedy, Sidney H ^a,b,f,g  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e Mathison Centre for Mental Health Research and Education   (Canada)

^f ST MICHAEL'S HOSPITAL   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

Frontolimbic; Major Depressive Disorder; Neuroimaging response biomarker; Pharmacotherapy; Psychotherapy; Stimulation therapy

Indexed keywords

ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER;

AMYGDALA; ANTERIOR CINGULATE; BRAIN REGION; DIFFUSION TENSOR IMAGING; EMBASE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HIPPOCAMPUS; HUMAN; INSULA; MAJOR DEPRESSION; MEDLINE; MULTIMODAL IMAGING; NEAR INFRARED SPECTROSCOPY; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOTHERAPY; PSYCINFO; REVIEW; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; TREATMENT RESPONSE; BRAIN; BRAIN CORTEX; CINGULATE GYRUS; PATHOPHYSIOLOGY; PROCEDURES; TEMPORAL LOBE; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; BIOMARKERS; BRAIN; CEREBRAL CORTEX; DEPRESSIVE DISORDER, MAJOR; FUNCTIONAL NEUROIMAGING; GYRUS CINGULI; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; PREFRONTAL CORTEX; PSYCHOTHERAPY; TEMPORAL LOBE; TREATMENT OUTCOME;

EID: 85033777247     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2017.10.049     Document Type: Review

References (113)

1. Abbott, C.C., Jones, T., Lemke, N.T., Gallegos, P., McClintock, S.M., Mayer, A.R., Bustillo, J., Calhoun, V.D., Hippocampal structural and functional changes associated with electroconvulsive therapy response. Transl. Psychiatry, 4, 2014, e483.
2. Accolla, E.A., Aust, S., Merkl, A., Schneider, G.H., Kuhn, A.A., Bajbouj, M., Draganski, B., Deep brain stimulation of the posterior gyrus rectus region for treatment resistant depression. J. Affect. Disord. 194 (2016), 33–37.
3. Alexopoulos, G.S., Hoptman, M.J., Kanellopoulos, D., Murphy, C.F., Lim, K.O., Gunning, F.M., Functional connectivity in the cognitive control network and the default mode network in late-life depression. J. Affect. Disord. 139 (2012), 56–65.
4. Amsterdam, J.D., Newberg, A.B., Newman, C.F., Shults, J., Wintering, N., Soeller, I., Change over time in brain serotonin transporter binding in major depression: effects of therapy measured with [(123)I]-ADAM SPECT. J. Neuroimaging: Off. J. Am. Soc. Neuroimaging 23 (2013), 469–476.
5. Andreescu, C., Tudorascu, D.L., Butters, M.A., Tamburo, E., Patel, M., Price, J., Karp, J.F., Reynolds, C.F. 3rd, Aizenstein, H., Resting state functional connectivity and treatment response in late-life depression. Psychiatry Res. 214 (2013), 313–321.
6. Baeken, C., De Raedt, R., Van Hove, C., Clerinx, P., De Mey, J., Bossuyt, A., HF-rTMS treatment in medication-resistant melancholic depression: results from 18FDG-PET brain imaging. CNS Spectr. 14 (2009), 439–448.
7. Baeken, C., Marinazzo, D., Everaert, H., Wu, G.R., Van Hove, C., Audenaert, K., Goethals, I., De Vos, F., Peremans, K., De Raedt, R., The impact of accelerated HF-rTMS on the subgenual anterior cingulate cortex in refractory unipolar major depression: insights from 18FDG PET brain imaging. Brain Stimul. 8 (2015), 808–815.
8. Baldwin, R., Jeffries, S., Jackson, A., Sutcliffe, C., Thacker, N., Scott, M., Burns, A., Treatment response in late-onset depression: relationship to neuropsychological, neuroradiological and vascular risk factors. Psychol. Med. 34 (2004), 125–136.
9. Bhagwagar, Z., Hinz, R., Taylor, M., Fancy, S., Cowen, P., Grasby, P., Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907. Am. J. Psychiatry 163 (2006), 1580–1587.
10. Bhagwagar, Z., Rabiner, E.A., Sargent, P.A., Grasby, P.M., Cowen, P.J., Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Mol. Psychiatry 9 (2004), 386–392.
11. Bremner, J.D., Narayan, M., Anderson, E.R., Staib, L.H., Miller, H.L., Charney, D.S., Hippocampal volume reduction in major depression. Am. J. Psychiatry 157 (2000), 115–118.
12. Bruder, G.E., Stewart, J.W., Tenke, C.E., McGrath, P.J., Leite, P., Bhattacharya, N., Quitkin, F.M., Electroencephalographic and perceptual asymmetry differences between responders and nonresponders to an SSRI antidepressant. Biol. Psychiatry 49 (2001), 416–425.
13. Cano, M., Cardoner, N., Urretavizcaya, M., Martinez-Zalacain, I., Goldberg, X., Via, E., Contreras-Rodriguez, O., Camprodon, J., de Arriba-Arnau, A., Hernandez-Ribas, R., Pujol, J., Soriano-Mas, C., Menchon, J.M., Modulation of limbic and prefrontal connectivity by electroconvulsive therapy in treatment-resistant depression: a preliminary study. Brain Stimul. 9 (2016), 65–71.
14. Cardoner, N., Pujol, J., Vallejo, J., Urretavizcaya, M., Deus, J., Lopez-Sala, A., Benlloch, L., Menchon, J.M., Enlargement of brain cerebrospinal fluid spaces as a predictor of poor clinical outcome in melancholia. J. Clin. Psychiatry 64 (2003), 691–697.
15. Conway, C.R., Chibnall, J.T., Gebara, M.A., Price, J.L., Snyder, A.Z., Mintun, M.A., Craig, A.D., Cornell, M.E., Perantie, D.C., Giuffra, L.A., Bucholz, R.D., Sheline, Y.I., Association of cerebral metabolic activity changes with vagus nerve stimulation antidepressant response in treatment-resistant depression. Brain Stimul. 6 (2013), 788–797.
16. Cook, I.A., Leuchter, A.F., Prefrontal changes and treatment response prediction in depression. Semin. Clin. Neuropsychiatry 6 (2001), 113–120.
17. Cook, I.A., Leuchter, A.F., Witte, E., Abrams, M., Uijtdehaage, S.H., Stubbeman, W., Rosenberg-Thompson, S., Anderson-Hanley, C., Dunkin, J.J., Neurophysiologic predictors of treatment response to fluoxetine in major depression. Psychiatry Res. 85 (1999), 263–273.
18. Costafreda, S.G., Chu, C., Ashburner, J., Fu, C.H., Prognostic and diagnostic potential of the structural neuroanatomy of depression. PLoS One, 4, 2009, e6353.
19. Costafreda, S.G., Khanna, A., Mourao-Miranda, J., Fu, C.H., Neural correlates of sad faces predict clinical remission to cognitive behavioural therapy in depression. Neuroreport 20 (2009), 637–641.
20. Cullen, K.R., Klimes-Dougan, B., Vu, D.P., Westlund Schreiner, M., Mueller, B.A., Eberly, L.E., Camchong, J., Westervelt, A., Lim, K.O., Neural correlates of antidepressant treatment response in adolescents with major depressive disorder. J. Child Adolesc. Psychopharmacol. 26 (2016), 705–712.
21. Depping, M.S., Nolte, H.M., Hirjak, D., Palm, E., Hofer, S., Stieltjes, B., Maier-Hein, K., Sambataro, F., Wolf, R.C., Thomann, P.A., Cerebellar volume change in response to electroconvulsive therapy in patients with major depression. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 73 (2017), 31–35.
22. Drysdale, A.T., Grosenick, L., Downar, J., Dunlop, K., Mansouri, F., Meng, Y., Fetcho, R.N., Zebley, B., Oathes, D.J., Etkin, A., Schatzberg, A.F., Sudheimer, K., Keller, J., Mayberg, H.S., Gunning, F.M., Alexopoulos, G.S., Fox, M.D., Pascual-Leone, A., Voss, H.U., Casey, B.J., Dubin, M.J., Liston, C., Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nat. Med. 23 (2017), 28–38.
23. Dubin, M.J., Mao, X., Banerjee, S., Goodman, Z., Lapidus, K.A., Kang, G., Liston, C., Shungu, D.C., Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy. J. Psychiatry Neurosci.: JPN 41 (2016), E37–E45.
24. Eschweiler, G.W., Wegerer, C., Schlotter, W., Spandl, C., Stevens, A., Bartels, M., Buchkremer, G., Left prefrontal activation predicts therapeutic effects of repetitive transcranial magnetic stimulation (rTMS) in major depression. Psychiatry Res. 99 (2000), 161–172.
25. Fitzgerald, P.B., Sritharan, A., Daskalakis, Z.J., de Castella, A.R., Kulkarni, J., Egan, G., A functional magnetic resonance imaging study of the effects of low frequency right prefrontal transcranial magnetic stimulation in depression. J. Clin. Psychopharmacol. 27 (2007), 488–492.
26. Forbes, E.E., Olino, T.M., Ryan, N.D., Birmaher, B., Axelson, D., Moyles, D.L., Dahl, R.E., Reward-related brain function as a predictor of treatment response in adolescents with major depressive disorder. Cogn. Affect. Behav. Neurosci. 10 (2010), 107–118.
27. Frodl, T., Jager, M., Smajstrlova, I., Born, C., Bottlender, R., Palladino, T., Reiser, M., Moller, H.J., Meisenzahl, E.M., Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study. J. Psychiatry Neurosci.: JPN 33 (2008), 423–430.
28. Frodl, T., Meisenzahl, E.M., Zetzsche, T., Hohne, T., Banac, S., Schorr, C., Jager, M., Leinsinger, G., Bottlender, R., Reiser, M., Moller, H.J., Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up. J. Clin. Psychiatry 65 (2004), 492–499.
29. Frodl, T., Scheuerecker, J., Schoepf, V., Linn, J., Koutsouleris, N., Bokde, A.L., Hampel, H., Moller, H.J., Bruckmann, H., Wiesmann, M., Meisenzahl, E., Different effects of mirtazapine and venlafaxine on brain activation: an open randomized controlled fMRI study. J. Clin. Psychiatry 72 (2011), 448–457.
30. Fu, C.H., Costafreda, S.G., Sankar, A., Adams, T.M., Rasenick, M.M., Liu, P., Donati, R., Maglanoc, L.A., Horton, P., Marangell, L.B., Multimodal functional and structural neuroimaging investigation of major depressive disorder following treatment with duloxetine. BMC Psychiatry, 15, 2015, 82.
31. Fu, C.H., Steiner, H., Costafreda, S.G., Predictive neural biomarkers of clinical response in depression: a meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies. Neurobiol. Dis. 52 (2013), 75–83.
32. Fu, C.H., Williams, S.C., Cleare, A.J., Scott, J., Mitterschiffthaler, M.T., Walsh, N.D., Donaldson, C., Suckling, J., Andrew, C., Steiner, H., Murray, R.M., Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biol. Psychiatry 64 (2008), 505–512.
33. Funahashi, S., Andreau, J.M., Prefrontal cortex and neural mechanisms of executive function. J. Physiol. 107 (2013), 471–482.
34. Furey, M.L., Drevets, W.C., Hoffman, E.M., Frankel, E., Speer, A.M., Zarate, C.A. Jr., Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder. JAMA Psychiatry 70 (2013), 280–290.
35. Furey, M.L., Drevets, W.C., Szczepanik, J., Khanna, A., Nugent, A., Zarate, C.A. Jr., Pretreatment differences in BOLD response to emotional faces correlate with antidepressant response to scopolamine. Int. J. Neuropsychopharmacol., 2015, 18.
36. Furtado, C.P., Hoy, K.E., Maller, J.J., Savage, G., Daskalakis, Z.J., Fitzgerald, P.B., Cognitive and volumetric predictors of response to repetitive transcranial magnetic stimulation (rTMS) – a prospective follow-up study. Psychiatry Res. 202 (2012), 12–19.
37. Furtado, C.P., Hoy, K.E., Maller, J.J., Savage, G., Daskalakis, Z.J., Fitzgerald, P.B., An investigation of medial temporal lobe changes and cognition following antidepressant response: a prospective rTMS study. Brain Stimul. 6 (2013), 346–354.
38. Goldapple, K., Segal, Z., Garson, C., Lau, M., Bieling, P., Kennedy, S., Mayberg, H., Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch. Gen. Psychiatry 61 (2004), 34–41.
39. Gray, N.A., Milak, M.S., DeLorenzo, C., Ogden, R.T., Huang, Y.Y., Mann, J.J., Parsey, R.V., Antidepressant treatment reduces serotonin-1A autoreceptor binding in major depressive disorder. Biol. Psychiatry 74 (2013), 26–31.
40. Gunning-Dixon, F.M., Walton, M., Cheng, J., Acuna, J., Klimstra, S., Zimmerman, M.E., Brickman, A.M., Hoptman, M.J., Young, R.C., Alexopoulos, G.S., MRI signal hyperintensities and treatment remission of geriatric depression. J. Affect. Disord. 126 (2010), 395–401.
41. Guo, W.B., Liu, F., Chen, J.D., Gao, K., Xue, Z.M., Xu, X.J., Wu, R.R., Tan, C.L., Sun, X.L., Liu, Z.N., Chen, H.F., Zhao, J.P., Abnormal neural activity of brain regions in treatment-resistant and treatment-sensitive major depressive disorder: a resting-state fMRI study. J. Psychiatr. Res. 46 (2012), 1366–1373.
42. Guo, W.B., Liu, F., Xue, Z.M., Xu, X.J., Wu, R.R., Ma, C.Q., Wooderson, S.C., Tan, C.L., Sun, X.L., Chen, J.D., Liu, Z.N., Xiao, C.Q., Chen, H.F., Zhao, J.P., Alterations of the amplitude of low-frequency fluctuations in treatment-resistant and treatment-response depression: a resting-state fMRI study. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 37 (2012), 153–160.
43. Gyurak, A., Patenaude, B., Korgaonkar, M.S., Grieve, S.M., Williams, L.M., Etkin, A., Frontoparietal activation during response inhibition predicts remission to antidepressants in patients with major depression. Biol. Psychiatry 79 (2016), 274–281.
44. Hanada, H., Imanaga, J., Yoshiiwa, A., Yoshikawa, T., Tanaka, Y., Tsuru, J., Inoue, A., Ishitobi, Y., Okamoto, S., Kanehisa, M., Maruyama, Y., Ninomiya, T., Higuma, H., Isogawa, K., Kawasaki, T., Fujioka, T., Akiyoshi, J., The value of ethyl cysteinate dimer single photon emission computed tomography in predicting antidepressant treatment response in patients with major depression. Int. J. Geriatr. Psychiatry 28 (2013), 756–765.
45. He, Z., Cui, Q., Zheng, J., Duan, X., Pang, Y., Gao, Q., Han, S., Long, Z., Wang, Y., Li, J., Wang, X., Zhao, J., Chen, H., Frequency-specific alterations in functional connectivity in treatment-resistant and -sensitive major depressive disorder. J. Psychiatr. Res. 82 (2016), 30–39.
46. Hoogenboom, W.S., Perlis, R.H., Smoller, J.W., Zeng-Treitler, Q., Gainer, V.S., Murphy, S.N., Churchill, S.E., Kohane, I.S., Shenton, M.E., Iosifescu, D.V., Limbic system white matter microstructure and long-term treatment outcome in major depressive disorder: a diffusion tensor imaging study using legacy data. World J. Biol. Psychiatry.: Off. J. World Fed. Soc. Biol. Psychiatry. 15 (2014), 122–134.
47. Hoy, K.E., Thomson, R.H., Cherk, M., Yap, K.S., Daskalakis, Z.J., Fitzgerald, P.B., Effect of magnetic seizure therapy on regional brain glucose metabolism in major depression. Psychiatry Res. 211 (2013), 169–175.
48. Hsieh, M.H., McQuoid, D.R., Levy, R.M., Payne, M.E., MacFall, J.R., Steffens, D.C., Hippocampal volume and antidepressant response in geriatric depression. Int. J. Geriatr. Psychiatry 17 (2002), 519–525.
49. Iosifescu, D.V., Renshaw, P.F., Lyoo, I.K., Lee, H.K., Perlis, R.H., Papakostas, G.I., Nierenberg, A.A., Fava, M., Brain white-matter hyperintensities and treatment outcome in major depressive disorder. Br. J. Psychiatry.: J. Ment. Sci. 188 (2006), 180–185.
50. Jaworska, N., Yucel, K., Courtright, A., MacMaster, F.P., Sembo, M., MacQueen, G., Subgenual anterior cingulate cortex and hippocampal volumes in depressed youth: the role of comorbidity and age. J. Affect. Disord. 190 (2016), 726–732.
51. Jha, S., Chadda, R.K., Kumar, N., Bal, C.S., Brain SPECT guided repetitive transcranial magnetic stimulation (rTMS) in treatment resistant major depressive disorder. Asian J. Psychiatry 21 (2016), 1–6.
52. Johansen-Berg, H., Gutman, D.A., Behrens, T.E., Matthews, P.M., Rushworth, M.F., Katz, E., Lozano, A.M., Mayberg, H.S., Anatomical connectivity of the subgenual cingulate region targeted with deep brain stimulation for treatment-resistant depression. Cereb. Cortex 18 (2008), 1374–1383.
53. Jung, J., Kang, J., Won, E., Nam, K., Lee, M.S., Tae, W.S., Ham, B.J., Impact of lingual gyrus volume on antidepressant response and neurocognitive functions in major depressive disorder: a voxel-based morphometry study. J. Affect. Disord. 169 (2014), 179–187.
54. Kayser, S., Bewernick, B.H., Grubert, C., Hadrysiewicz, B.L., Axmacher, N., Schlaepfer, T.E., Antidepressant effects, of magnetic seizure therapy and electroconvulsive therapy, in treatment-resistant depression. J. Psychiatr. Res. 45 (2011), 569–576.
55. Keedwell, P.A., Drapier, D., Surguladze, S., Giampietro, V., Brammer, M., Phillips, M., Subgenual cingulate and visual cortex responses to sad faces predict clinical outcome during antidepressant treatment for depression. J. Affect. Disord. 120 (2010), 120–125.
56. Kennedy, S.H., Downar, J., Evans, K.R., Feilotter, H., Lam, R.W., MacQueen, G.M., Milev, R., Parikh, S.V., Rotzinger, S., Soares, C., The Canadian Biomarker Integration Network in Depression (CAN-BIND): advances in response prediction. Curr. Pharm. Des. 18 (2012), 5976–5989.
57. Kennedy, S.H., Giacobbe, P., Rizvi, S.J., Placenza, F.M., Nishikawa, Y., Mayberg, H.S., Lozano, A.M., Deep brain stimulation for treatment-resistant depression: follow-up after 3–6 years. Am. J. Psychiatry 168 (2011), 502–510.
58. Kennedy, S.H., Konarski, J.Z., Segal, Z.V., Lau, M.A., Bieling, P.J., McIntyre, R.S., Mayberg, H.S., Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am. J. Psychiatry 164 (2007), 778–788.
59. Khalaf, A., Edelman, K., Tudorascu, D., Andreescu, C., Reynolds, C.F., Aizenstein, H., White matter hyperintensity accumulation during treatment of late-life depression. Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol. 40 (2015), 3027–3035.
60. Kito, S., Hasegawa, T., Koga, Y., Cerebral blood flow ratio of the dorsolateral prefrontal cortex to the ventromedial prefrontal cortex as a potential predictor of treatment response to transcranial magnetic stimulation in depression. Brain Stimul. 5 (2012), 547–553.
61. Konarski, J.Z., Kennedy, S.H., Segal, Z.V., Lau, M.A., Bieling, P.J., McIntyre, R.S., Mayberg, H.S., Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. J. Psychiatry Neurosci.: JPN 34 (2009), 175–180.
62. Kozak, M.J., Cuthbert, B.N., The NIMH research domain criteria initiative: background, issues, and pragmatics. Psychophysiology 53 (2016), 286–297.
63. Lam, R.W., McIntosh, D., Wang, J., Enns, M.W., Kolivakis, T., Michalak, E.E., Sareen, J., Song, W.Y., Kennedy, S.H., MacQueen, G.M., Milev, R.V., Parikh, S.V., Ravindran, A.V., Group, C.D.W., Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 1. Disease burden and principles of care. Can. J. Psychiatry Rev. Can. De. Psychiatr. 61 (2016), 510–523.
64. Langenecker, S.A., Kennedy, S.E., Guidotti, L.M., Briceno, E.M., Own, L.S., Hooven, T., Young, E.A., Akil, H., Noll, D.C., Zubieta, J.K., Frontal and limbic activation during inhibitory control predicts treatment response in major depressive disorder. Biol. Psychiatry 62 (2007), 1272–1280.
65. Lanzenberger, R., Baldinger, P., Hahn, A., Ungersboeck, J., Mitterhauser, M., Winkler, D., Micskei, Z., Stein, P., Karanikas, G., Wadsak, W., Kasper, S., Frey, R., Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET. Mol. Psychiatry 18 (2013), 93–100.
66. Li, C.T., Lin, C.P., Chou, K.H., Chen, I.Y., Hsieh, J.C., Wu, C.L., Lin, W.C., Su, T.P., Structural and cognitive deficits in remitting and non-remitting recurrent depression: a voxel-based morphometric study. NeuroImage 50 (2010), 347–356.
67. Li, C.T., Wang, S.J., Hirvonen, J., Hsieh, J.C., Bai, Y.M., Hong, C.J., Liou, Y.J., Su, T.P., Antidepressant mechanism of add-on repetitive transcranial magnetic stimulation in medication-resistant depression using cerebral glucose metabolism. J. Affect. Disord. 127 (2010), 219–229.
68. Liu, F., Guo, W., Yu, D., Gao, Q., Gao, K., Xue, Z., Du, H., Zhang, J., Tan, C., Liu, Z., Zhao, J., Chen, H., Classification of different therapeutic responses of major depressive disorder with multivariate pattern analysis method based on structural MR scans. PLoS One, 7, 2012, e40968.
69. Lozano, A.M., Mayberg, H.S., Giacobbe, P., Hamani, C., Craddock, R.C., Kennedy, S.H., Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol. Psychiatry 64 (2008), 461–467.
70. Luborzewski, A., Schubert, F., Seifert, F., Danker-Hopfe, H., Brakemeier, E.L., Schlattmann, P., Anghelescu, I., Colla, M., Bajbouj, M., Metabolic alterations in the dorsolateral prefrontal cortex after treatment with high-frequency repetitive transcranial magnetic stimulation in patients with unipolar major depression. J. Psychiatr. Res. 41 (2007), 606–615.
71. Lyden, H., Espinoza, R.T., Pirnia, T., Clark, K., Joshi, S.H., Leaver, A.M., Woods, R.P., Narr, K.L., Electroconvulsive therapy mediates neuroplasticity of white matter microstructure in major depression. Transl. Psychiatry, 4, 2014, e380.
72. MacQueen, G., Frodl, T., The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research?. Mol. Psychiatry 16 (2011), 252–264.
73. Macqueen, G.M., Will there be a role for neuroimaging in clinical psychiatry?. J. Psychiatry Neurosci.: JPN 35 (2010), 291–293.
74. MacQueen, G.M., Yucel, K., Taylor, V.H., Macdonald, K., Joffe, R., Posterior hippocampal volumes are associated with remission rates in patients with major depressive disorder. Biol. Psychiatry 64 (2008), 880–883.
75. Mayberg, H.S., Brannan, S.K., Tekell, J.L., Silva, J.A., Mahurin, R.K., McGinnis, S., Jerabek, P.A., Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol. Psychiatry 48 (2000), 830–843.
76. McGrath, C.L., Kelley, M.E., Dunlop, B.W., Holtzheimer, P.E. 3rd, Craighead, W.E., Mayberg, H.S., Pretreatment brain states identify likely nonresponse to standard treatments for depression. Biol. Psychiatry 76 (2014), 527–535.
77. McGrath, C.L., Kelley, M.E., Holtzheimer, P.E., Dunlop, B.W., Craighead, W.E., Franco, A.R., Craddock, R.C., Mayberg, H.S., Toward a neuroimaging treatment selection biomarker for major depressive disorder. JAMA Psychiatry 70 (2013), 821–829.
78. Milak, M.S., Parsey, R.V., Lee, L., Oquendo, M.A., Olvet, D.M., Eipper, F., Malone, K., Mann, J.J., Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment. Psychiatry Res. 173 (2009), 63–70.
79. Miller, J.M., Schneck, N., Siegle, G.J., Chen, Y., Ogden, R.T., Kikuchi, T., Oquendo, M.A., Mann, J.J., Parsey, R.V., fMRI response to negative words and SSRI treatment outcome in major depressive disorder: a preliminary study. Psychiatry Res. 214 (2013), 296–305.
80. Milo, T.J., Kaufman, G.E., Barnes, W.E., Konopka, L.M., Crayton, J.W., Ringelstein, J.G., Shirazi, P.H., Changes in regional cerebral blood flow after electroconvulsive therapy for depression. J. ECT 17 (2001), 15–21.
81. Nase, S., Kohler, S., Jennebach, J., Eckert, A., Schweinfurth, N., Gallinat, J., Lang, U.E., Kuhn, S., Role of serum brain derived neurotrophic factor and central N-acetylaspartate for clinical response under antidepressive pharmacotherapy. Neuro-Signals 24 (2016), 1–14.
82. Nickl-Jockschat, T., Palomero Gallagher, N., Kumar, V., Hoffstaedter, F., Brugmann, E., Habel, U., Eickhoff, S.B., Grozinger, M., Are morphological changes necessary to mediate the therapeutic effects of electroconvulsive therapy?. Eur. Arch. Psychiatry Clin. Neurosci. 266 (2016), 261–267.
83. Nord, C.L., Gray, A., Charpentier, C.J., Robinson, O.J., Roiser, J.P., Unreliability of putative fMRI biomarkers during emotional face processing. NeuroImage 156 (2017), 119–127.
84. Oudega, M.L., van Exel, E., Stek, M.L., Wattjes, M.P., van der Flier, W.M., Comijs, H.C., Dols, A., Scheltens, P., Barkhof, F., Eikelenboom, P., van den Heuvel, O.A., The structure of the geriatric depressed brain and response to electroconvulsive therapy. Psychiatry Res. 222 (2014), 1–9.
85. Oudega, M.L., van Exel, E., Wattjes, M.P., Comijs, H.C., Scheltens, P., Barkhof, F., Eikelenboom, P., de Craen, A.J., Beekman, A.T., Stek, M.L., White matter hyperintensities, medial temporal lobe atrophy, cortical atrophy, and response to electroconvulsive therapy in severely depressed elderly patients. J. Clin. Psychiatry 72 (2011), 104–112.
86. Patankar, T.F., Baldwin, R., Mitra, D., Jeffries, S., Sutcliffe, C., Burns, A., Jackson, A., Virchow-Robin space dilatation may predict resistance to antidepressant monotherapy in elderly patients with depression. J. Affect. Disord. 97 (2007), 265–270.
87. Phillips, J.L., Batten, L.A., Aldosary, F., Tremblay, P., Blier, P., Brain-volume increase with sustained remission in patients with treatment-resistant unipolar depression. J. Clin. Psychiatry 73 (2012), 625–631.
88. Pujol, J., Cardoner, N., Benlloch, L., Urretavizcaya, M., Deus, J., Losilla, J.M., Capdevila, A., Vallejo, J., CSF spaces of the Sylvian fissure region in severe melancholic depression. NeuroImage 15 (2002), 103–106.
89. Ritchey, M., Dolcos, F., Eddington, K.M., Strauman, T.J., Cabeza, R., Neural correlates of emotional processing in depression: changes with cognitive behavioral therapy and predictors of treatment response. J. Psychiatr. Res. 45 (2011), 577–587.
90. Rizvi, S.J., Salomons, T.V., Konarski, J.Z., Downar, J., Giacobbe, P., McIntyre, R.S., Kennedy, S.H., Neural response to emotional stimuli associated with successful antidepressant treatment and behavioral activation. J. Affect. Disord. 151 (2013), 573–581.
91. Ruhe, H.G., Booij, J., Veltman, D.J., Michel, M.C., Schene, A.H., Successful pharmacologic treatment of major depressive disorder attenuates amygdala activation to negative facial expressions: a functional magnetic resonance imaging study. J. Clin. Psychiatry 73 (2012), 451–459.
92. Saijo, T., Takano, A., Suhara, T., Arakawa, R., Okumura, M., Ichimiya, T., Ito, H., Okubo, Y., Electroconvulsive therapy decreases dopamine D(2)receptor binding in the anterior cingulate in patients with depression: a controlled study using positron emission tomography with radioligand [(1)(1)C]FLB 457. J. Clin. Psychiatry 71 (2010), 793–799.
93. Schmaal, L., Veltman, D.J., van Erp, T.G., Samann, P.G., Frodl, T., Jahanshad, N., Loehrer, E., Tiemeier, H., Hofman, A., Niessen, W.J., Vernooij, M.W., Ikram, M.A., Wittfeld, K., Grabe, H.J., Block, A., Hegenscheid, K., Volzke, H., Hoehn, D., Czisch, M., Lagopoulos, J., Hatton, S.N., Hickie, I.B., Goya-Maldonado, R., Kramer, B., Gruber, O., Couvy-Duchesne, B., Renteria, M.E., Strike, L.T., Mills, N.T., de Zubicaray, G.I., McMahon, K.L., Medland, S.E., Martin, N.G., Gillespie, N.A., Wright, M.J., Hall, G.B., MacQueen, G.M., Frey, E.M., Carballedo, A., van Velzen, L.S., van Tol, M.J., van der Wee, N.J., Veer, I.M., Walter, H., Schnell, K., Schramm, E., Normann, C., Schoepf, D., Konrad, C., Zurowski, B., Nickson, T., McIntosh, A.M., Papmeyer, M., Whalley, H.C., Sussmann, J.E., Godlewska, B.R., Cowen, P.J., Fischer, F.H., Rose, M., Penninx, B.W., Thompson, P.M., Hibar, D.P., Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group. Mol. Psychiatry 21 (2016), 806–812.
94. Siegle, G.J., Thompson, W.K., Collier, A., Berman, S.R., Feldmiller, J., Thase, M.E., Friedman, E.S., Toward clinically useful neuroimaging in depression treatment: prognostic utility of subgenual cingulate activity for determining depression outcome in cognitive therapy across studies, scanners, and patient characteristics. Arch. Gen. Psychiatry 69 (2012), 913–924.
95. Simpson, S.W., Baldwin, R.C., Burns, A., Jackson, A., Regional cerebral volume measurements in late-life depression: relationship to clinical correlates, neuropsychological impairment and response to treatment. Int. J. Geriatr. Psychiatry 16 (2001), 469–476.
96. Simpson, S.W., Jackson, A., Baldwin, R.C., Burns, A., 1997 IPA/Bayer research awards in psychogeriatrics. Subcortical hyperintensities in late-life depression: acute response to treatment and neuropsychological impairment. Int. Psychogeriatr. 9 (1997), 257–275.
97. Straub, J., Metzger, C.D., Plener, P.L., Koelch, M.G., Groen, G., Abler, B., Successful group psychotherapy of depression in adolescents alters fronto-limbic resting-state connectivity. J. Affect. Disord. 209 (2017), 135–139.
98. Szczepanik, J., Nugent, A.C., Drevets, W.C., Khanna, A., Zarate, C.A. Jr., Furey, M.L., Amygdala response to explicit sad face stimuli at baseline predicts antidepressant treatment response to scopolamine in major depressive disorder. Psychiatry Res. 254 (2016), 67–73.
99. Taylor, W.D., Aizenstein, H.J., Alexopoulos, G.S., The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol. Psychiatry 18 (2013), 963–974.
100. Ten Doesschate, F., van Eijndhoven, P., Tendolkar, I., van Wingen, G.A., van Waarde, J.A., Pre-treatment amygdala volume predicts electroconvulsive therapy response. Front. Psychiatry, 5, 2014, 169.
101. Thompson, P.M., Stein, J.L., Medland, S.E., Hibar, D.P., Vasquez, A.A., Renteria, M.E., Toro, R., Jahanshad, N., Schumann, G., Franke, B., Wright, M.J., Martin, N.G., Agartz, I., Alda, M., Alhusaini, S., Almasy, L., Almeida, J., Alpert, K., Andreasen, N.C., Andreassen, O.A., Apostolova, L.G., Appel, K., Armstrong, N.J., Aribisala, B., Bastin, M.E., Bauer, M., Bearden, C.E., Bergmann, O., Binder, E.B., Blangero, J., Bockholt, H.J., Boen, E., Bois, C., Boomsma, D.I., Booth, T., Bowman, I.J., Bralten, J., Brouwer, R.M., Brunner, H.G., Brohawn, D.G., Buckner, R.L., Buitelaar, J., Bulayeva, K., Bustillo, J.R., Calhoun, V.D., Cannon, D.M., Cantor, R.M., Carless, M.A., Caseras, X., Cavalleri, G.L., Chakravarty, M.M., Chang, K.D., Ching, C.R., Christoforou, A., Cichon, S., Clark, V.P., Conrod, P., Coppola, G., Crespo-Facorro, B., Curran, J.E., Czisch, M., Deary, I.J., de Geus, E.J., den Braber, A., Delvecchio, G., Depondt, C., de Haan, L., de Zubicaray, G.I., Dima, D., Dimitrova, R., Djurovic, S., Dong, H., Donohoe, G., Duggirala, R., Dyer, T.D., Ehrlich, S., Ekman, C.J., Elvsashagen, T., Emsell, L., Erk, S., Espeseth, T., Fagerness, J., Fears, S., Fedko, I., Fernandez, G., Fisher, S.E., Foroud, T., Fox, P.T., Francks, C., Frangou, S., Frey, E.M., Frodl, T., Frouin, V., Garavan, H., Giddaluru, S., Glahn, D.C., Godlewska, B., Goldstein, R.Z., Gollub, R.L., Grabe, H.J., Grimm, O., Gruber, O., Guadalupe, T., Gur, R.E., Gur, R.C., Goring, H.H., Hagenaars, S., Hajek, T., Hall, G.B., Hall, J., Hardy, J., Hartman, C.A., Hass, J., Hatton, S.N., Haukvik, U.K., Hegenscheid, K., Heinz, A., Hickie, I.B., Ho, B.C., Hoehn, D., Hoekstra, P.J., Hollinshead, M., Holmes, A.J., Homuth, G., Hoogman, M., Hong, L.E., Hosten, N., Hottenga, J.J., Hulshoff Pol, H.E., Hwang, K.S., Jack, C.R. Jr., Jenkinson, M., Johnston, C., Jonsson, E.G., Kahn, R.S., Kasperaviciute, D., Kelly, L., Kim, S., Kochunov, P., Koenders, L., Thompson, B., Kwok, J.B., Lagopoulos, J., Laje, G., Landen, M., Landman, B.A., Lauriello, J., Lawrie, S.M., Blangero, P.H., Le Hellard, S., Lemaitre, H., Leonardo, C.D., Li, C.S., Liberg, B., Liewald, D.C., Liu, X., Lopez, L.M., Loth, E., Lourdusamy, A., Luciano, M., Macciardi, F., Machielsen, M.W., Macqueen, G.M., Malt, U.F., Mandl, R., Manoach, D.S., Martinot, J.L., Matarin, M., Mather, K.A., Mattheisen, M., Mattingsdal, G., Meyer-Lindenberg, A., McDonald, C., McIntosh, A.M., McMahon, F.J., McMahon, K.L., Meisenzahl, E., Melle, I., Milaneschi, Y., Mohnke, S., Montgomery, G.W., Morris, D.W., Moses, E.K., Mueller, B.A., Munoz Maniega, S., Muhleisen, T.W., Muller-Myhsok, B., Mwangi, C., Nauck, M., Nho, K., Nichols, T.E., Nilsson, L.G., Nugent, A.C., Nyberg, L., Olvera, R.L., Oosterlaan, J., Ophoff, R.A., Pandolfo, M., Papalampropoulou-Tsiridou, M., Papmeyer, M., Paus, T., Pausova, Z., Pearlson, G.D., Penninx, B.W., Peterson, C.P., Pfennig, A., Phillips, M., Pike, G.B., Poline, J.B., Potkin, S.G., Putz, B., Ramasamy, A., Rasmussen, J., Rietschel, M., Rijpkema, M., Risacher, S.L., Roffman, J.L., Roiz-Santianez, R., Romanczuk-Seiferth, N., Rose, E.J., Royle, N.A., Muller-Myhsok, D., Ryten, M., Sachdev, P.S., Salami, A., Satterthwaite, T.D., Savitz, J., Saykin, A.J., Scanlon, C., Schmaal, L., Schnack, H.G., Schork, A.J., Schulz, S.C., Schur, R., Hulshoff Pol, D., Shen, L., Shoemaker, J.M., Simmons, A., Sisodiya, S.M., Smith, C., Smoller, J.W., Soares, J.C., Sponheim, S.R., Sprooten, E., Starr, J.M., Steen, V.M., Strakowski, S., Strike, L., Sussmann, J., Samann, P.G., Teumer, A., Toga, E., Tordesillas-Gutierrez, D., Trabzuni, D., Trost, S., Turner, J., Van den Heuvel, M., van der Wee, N.J., van Eijk, K., van Erp, T.G., van Haren, N.E., van ‘t Ent, D., van Tol, M.J., Valdes Hernandez, M.C., Veltman, D.J., Versace, A., Volzke, H., Walker, R., Walter, H., Wang, L., Wardlaw, J.M., Weale, M.E., Weiner, M.W., Wen, W., Westlye, A.J., Whalley, G.I., Whelan, C.D., White, T., Winkler, A.M., Wittfeld, K., Woldehawariat, G., Wolf, C., Zilles, D., Zwiers, M.P., Thalamuthu, A., Schofield, P.R., Freimer, N.B., Lawrence, N.S., Drevets, W., Alzheimer's Disease Neuroimaging Initiative, E.C.I.C.S.Y.S.G. The ENIGMA consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav. 8 (2014), 153–182.
102. Tiger, M., Ruck, C., Forsberg, A., Varrone, A., Lindefors, N., Halldin, C., Farde, L., Lundberg, J., Reduced 5-HT(1B) receptor binding in the dorsal brain stem after cognitive behavioural therapy of major depressive disorder. Psychiatry Res. 223 (2014), 164–170.
103. Toki, S., Okamoto, Y., Onoda, K., Matsumoto, T., Yoshimura, S., Kunisato, Y., Okada, G., Shishida, K., Kobayakawa, M., Fukumoto, T., Machino, A., Inagaki, M., Yamawaki, S., Hippocampal activation during associative encoding of word pairs and its relation to symptomatic improvement in depression: a functional and volumetric MRI study. J. Affect. Disord. 152–154 (2014), 462–467.
104. Vakili, K., Pillay, S.S., Lafer, B., Fava, M., Renshaw, P.F., Bonello-Cintron, C.M., Yurgelun-Todd, D.A., Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study. Biol. Psychiatry 47 (2000), 1087–1090.
105. van Dinteren, R., Arns, M., Kenemans, L., Jongsma, M.L., Kessels, R.P., Fitzgerald, P., Fallahpour, K., Debattista, C., Gordon, E., Williams, L.M., Utility of event-related potentials in predicting antidepressant treatment response: an iSPOT-D report. Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol. 25 (2015), 1981–1990.
106. Via, E., Cardoner, N., Pujol, J., Martinez-Zalacain, I., Hernandez-Ribas, R., Urretavizacaya, M., Lopez-Sola, M., Deus, J., Menchon, J.M., Soriano-Mas, C., Cerebrospinal fluid space alterations in melancholic depression. PLoS One, 7, 2012, e38299.
107. Wang, L., Xia, M., Li, K., Zeng, Y., Su, Y., Dai, W., Zhang, Q., Jin, Z., Mitchell, P.B., Yu, X., He, Y., Si, T., The effects of antidepressant treatment on resting-state functional brain networks in patients with major depressive disorder. Hum. Brain Mapp. 36 (2015), 768–778.
108. Wang, L.J., Kuang, W.H., Xu, J.J., Lei, D., Yang, Y.C., Resting-state brain activation correlates with short-time antidepressant treatment outcome in drug-naive patients with major depressive disorder. J. Int. Med. Res. 42 (2014), 966–975.
109. Williams, L.M., Korgaonkar, M.S., Song, Y.C., Paton, R., Eagles, S., Goldstein-Piekarski, A., Grieve, S.M., Harris, A.W., Usherwood, T., Etkin, A., Amygdala reactivity to emotional faces in the prediction of general and medication-specific responses to antidepressant treatment in the randomized iSPOT-D trial. Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol. 40 (2015), 2398–2408.
110. Yang, X.R., Kirton, A., Wilkes, T.C., Pradhan, S., Liu, I., Jaworska, N., Damji, O., Keess, J., Langevin, L.M., Rajapakse, T., Lebel, R.M., Sembo, M., Fife, M., MacMaster, F.P., Glutamate alterations associated with transcranial magnetic stimulation in youth depression: a case series. J. ECT 30 (2014), 242–247.
111. Yatham, L.N., Liddle, P.F., Lam, R.W., Zis, A.P., Stoessl, A.J., Sossi, V., Adam, M.J., Ruth, T.J., Effect of electroconvulsive therapy on brain 5-HT(2) receptors in major depression. Br. J. Psychiatry.: J. Ment. Sci. 196 (2010), 474–479.
112. Yeh, Y.W., Ho, P.S., Kuo, S.C., Chen, C.Y., Liang, C.S., Yen, C.H., Huang, C.C., Ma, K.H., Shiue, C.Y., Huang, W.S., Shyu, J.F., Wan, F.J., Lu, R.B., Huang, S.Y., Disproportionate reduction of serotonin transporter may predict the response and adherence to antidepressants in patients with major depressive disorder: a positron emission tomography study with 4-[18F]-ADAM. Int. J. Neuropsychopharmacol., 18, 2015, pyu120.
113. Zheng, H., Zhang, L., Li, L., Liu, P., Gao, J., Liu, X., Zou, J., Zhang, Y., Liu, J., Zhang, Z., Li, Z., Men, W., High-frequency rTMS treatment increases left prefrontal myo-inositol in young patients with treatment-resistant depression. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 34 (2010), 1189–1195.